Researchers at VCU Massey Cancer Center published study findings that establish rationale for the use of a class of drugs known as MDA-9 inhibitors as a potential treatment option for aggressive liver cancer.
The VCU Massey Comprehensive Cancer Center completed the inaugural funding cycle of its VCU–Sanford Burnham Prebys Drug Discovery Collaborative Program, a collaboration with the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA.
